D
Axsome Therapeutics, Inc. AXSM
$121.91 $0.260.21%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -15.96% 18.58% -16.07% 30.71% -58.61%
Total Depreciation and Amortization 0.58% 3.41% 8.85% 5.23% -0.17%
Total Amortization of Deferred Charges 5.36% 4.84% 3.55% 36.34% -27.59%
Total Other Non-Cash Items -13.30% 61.09% 23.24% -69.29% 311.14%
Change in Net Operating Assets 154.61% -78.03% 436.14% -298.74% 138.22%
Cash from Operations -40.64% 38.12% 43.68% -76.10% 43.30%
Capital Expenditure 66.67% -73.08% 46.94% -1,300.00% 98.11%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing 66.67% -73.08% 46.94% -1,300.00% 98.11%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -6.11% -67.20% -14.11% -- --
Issuance of Common Stock -47.39% 85.45% 619.91% 118.43% -96.99%
Repurchase of Common Stock -12.68% 64.38% 17.92% -477.86% 21.13%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -11.72% -4.21% -10.80% -119.95% 80.03%
Cash from Financing -53.15% 111.47% 1,311.29% -59,250.00% -100.01%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -202.60% 174.02% 71.17% -80.28% -47.80%
Weiss Ratings